Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

(2011) E. Doubrovina et al.   BLOOD

Unmanipulated Donor Lymphocytes for EBV-Related PTLD After T-Cell Depleted HLA-Haploidentical Transplantation

(2011) M. D. De Pasquale et al.   PEDIATRICS

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

(2010) J. N. Barker et al.   BLOOD

Prospective Evaluation of Epstein–Barr Virus Reactivation After Stem Cell Transplantation: Association with Monoclonal Gammopathy

(2010) Patrizia Chiusolo et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Lymphoma Recurrence 5 Years or Later Following Diffuse Large B-Cell Lymphoma: Clinical Characteristics and Outcome

(2010) Jean-François Larouche et al.   JOURNAL OF CLINICAL ONCOLOGY

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation

(2010) Simone Cesaro et al.   TRANSPLANTATION

Rituximab reduces the incidence of acute graft-versus-host disease

(2009) M. Christopeit et al.   BLOOD

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children

(2009) M Faraci et al.   BONE MARROW TRANSPLANTATION

Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients

(2009) Arjan Diepstra et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

(2008) J Styczynski et al.   BONE MARROW TRANSPLANTATION

Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency

(2008) Maura Faraci et al.   PEDIATRIC TRANSPLANTATION